What is BioArctic AB (BIOA B)?
BioArctic AB is a biopharmaceutical company focused on the development of treatments for neurodegenerative diseases and central nervous system disorders. The company engages in research and development activities targeting conditions such as Alzheimer's disease and Parkinson's disease. BioArctic's pipeline includes therapeutic antibodies and other biologics designed to modify disease progression. The company collaborates with academic institutions and pharmaceutical partners to advance its clinical programs. BioArctic operates with an emphasis on innovation in neuroscience and aims to address unmet medical needs through novel therapeutic approaches. Its work contributes to the broader field of neurodegenerative disease research.
BioArctic AB Stock Price Today: Live Overview
The price today is shaped by market fluctuations seen in BioArctic AB, currently trading at kr308.15. The price has moved within a daily range of kr294.3 to kr310.45, showing a daily percentage change of 0%.
FAQ: BioArctic AB (BIOA B)
What is the current price of BIOA B stock?
The current price is kr308.15.
Does BIOA B pay dividends?
Dividends are paid via cash distributions (if applicable).
Does BIOA B have a formal corporate presence or regional headquarters in the UAE?
BioArctic AB does not have an official regional office or subsidiary in the UAE and operates via partners.
What is BIOA B best known for?
The company is most famous for its biopharmaceutical research and development in neurodegenerative diseases.
What assets are typically shown together with BIOA B?
Commonly shown alongside BIOA B: Paradigm Biopharmaceuticals Limited, TriplePoint Venture Growth BDC Corp, ProShares Ultra Real Estate
Latest shares articles



